Week's top
Latest news
Unread news
Subscribe

Science X Account

Remember me

Click here to sign in with or

Forget Password?

Not a member? Sign up

Addiction
Alzheimer's disease & dementia
Arthritis & Rheumatism
Attention deficit disorders
Autism spectrum disorders
Biomedical technology
Cardiology
Dentistry
Diabetes
Diseases, Conditions, Syndromes
Endocrinology & Metabolism
Gastroenterology

Genetics
Gerontology & Geriatrics
Health
Health informatics
HIV & AIDS
Immunology
Inflammatory disorders
Medical economics
Medical research
Medications
Neuroscience
Obstetrics & gynaecology

Oncology & Cancer
Ophthalmology
Other
Overweight & Obesity
Parkinson's & Movement disorders
Pediatrics
Psychology & Psychiatry
Radiology & Imaging
Sleep disorders
Sports medicine & Kinesiology
Surgery
Vaccination

Asthma
Breast cancer
Cardiovascular disease
Chronic obstructive pulmonary disease
Colon cancer
Coronary artery disease

Dementia
Depression
Heart attack
Heart disease
High blood pressure
Influenza

Kidney disease
Leukemia
Lung cancer
Malaria
Melanoma
Multiple sclerosis

Myocardial infarction
Ovarian cancer
Post traumatic stress disorder
Rheumatoid arthritis
Schizophrenia
Skin cancer

Stroke
Type 2 diabetes
Full List »

Home
Archive
16/02/2021

Archive: 16/02/2021

Combination treatment for common glioma type shows promise in mice

Gliomas are common brain tumors that comprise about one third of all cancers of the nervous system. In a study funded by the National Institutes of Health (NIH), researchers tested a novel combination treatment approach on ...

Feb 16, 2021

0

15

Antibody-based COVID-19 treatments work best in concert with immune cells

Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made ...

Feb 16, 2021

0

168

Researchers take early step toward leukemia drug therapy

A McMaster stem cell research team has made an important early step in developing a new class of therapeutics for patients with a deadly blood cancer.

Feb 16, 2021

0

10

Identifying 'ugly ducklings' to catch skin cancer earlier

Melanoma is by far the deadliest form of skin cancer, killing more than 7,000 people in the United States in 2019 alone. Early detection of the disease dramatically reduces the risk of death and the costs of treatment, but ...

Feb 16, 2021

1

193

Molecular imaging determines effectiveness of novel metastatic breast cancer treatment

Molecular imaging can successfully predict response to a novel treatment for ER-positive, HER2-negative metastatic breast cancer patients who are resistant to hormonal therapy. According to research published in the February ...

Feb 16, 2021

0

0

Type 2 diabetes drug shows promise against obesity, study suggests. But it's expensive

A new drug has been found to be so effective against obesity that it may help patients avoid consequences such as diabetes and hypertension, according to a study published in the New England Journal of Medicine last week.

Feb 16, 2021

0

8

Neandertal gene variants both increase and decrease the risk for severe COVID-19

Last year, researchers at Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany showed that a major genetic risk factor for severe COVID-19 is inherited from Neandertals. ...

Feb 16, 2021

0

452

Five tips to love your heart

Heart disease remains the No. 1 cause of death in the U.S., with over 655,000 dying annually, according to the American Heart Association. In an ongoing effort to raise awareness around heart health and help prevent heart ...

Feb 16, 2021

0

5

Understanding the DNA repair toolkit to chart cancer evolution

The ongoing fight of science against cancer has made great strides, but cancer cells have not made it easy. The complexity of cancer cells and their adaptive evolutionary nature complicate the search for effective cures. ...

Feb 16, 2021

0

15

Targeted elimination of leukemic stem cells

Leukemia is caused by leukemic stem cells which are resistant to most known therapies. Relapses are also due to this resistance. Leukemic stem cells arise from normal blood-forming (hematopoietic) stem cells. Because they ...

Feb 16, 2021

0

7

page 3 from 12

«
»

Phys.org — Phys.org

Daily science news on research developments and the latest scientific innovations

Tech Xplore

The latest engineering, electronics and technology advances

ScienceX — Science X

The most comprehensive sci-tech news coverage on the web

Newsletters

Science X Daily and the Weekly Email Newsletter are free features that allow you to receive your favorite sci-tech news updates in your email inbox

Follow us

Top
Home
Search
Mobile version

Help
FAQ
About
Contact

Science X Account
Premium Account
Newsletter
Archive

Android app
iOS app
RSS feeds
Push notification

© Medical Xpress 2011 - 2024 powered by Science X Network

Privacy policy Terms of use Medical Disclaimer

E-mail newsletter

Follow us